Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study

被引：0
|
作者：
Hendrik G Bremer
Ingrid van Rooy
Bas Pullens
Carla Colijn
Inge Stegeman
Hester J van der Zaag-Loonen
Peter Paul van Benthem
Sjaak F L Klis
Wilko Grolman
Tjasse D Bruintjes
机构：
[1] University Medical Center Utrecht,Department of Otorhinolaryngology
[2] University Medical Center,Brain Center Rudolf Magnus
[3] Gelre Ziekenhuizen Apeldoorn,Department of Otorhinolaryngology
[4] Gelre Ziekenhuizen Apeldoorn,Department of Biometry
[5] Erasmus Medical Center/ Sophia Children’s Hospital,Department of Otorhinolaryngology
来源：
Trials | / 15卷
关键词：
Aminoglycosides; Gentamicin; Intratympanic; Ménière’s disease; DHI; Audiometry; RCT; Double-blind design; Adverse event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Intratympanic gentamicin treatment for Meniere's disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study
    Bremer, Hendrik G.
    van Rooy, Ingrid
    Pullens, Bas
    Colijn, Carla
    Stegeman, Inge
    van der Zaag-Loonen, Hester J.
    van Benthem, Peter Paul
    Klis, Sjaak F. L.
    Grolman, Wilko
    Bruintjes, Tjasse D.
    TRIALS, 2014, 15
  • [2] EFFICACY OF INTRATYMPANIC OTO-104 FOR THE TREATMENT OF MÉNIÈRE'S DISEASE: THE OUTCOME OF THREE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Scarpa, Alfonso
    Carucci, Mario
    Ralli, Massimo
    De Luca, Pietro
    Salzano, Giovanni
    Viola, Pasquale
    Chiarella, Giuseppe
    Francesco, Antonio Salzano
    OTOLOGY & NEUROTOLOGY, 2024, 45 (09) : 1087 - 1088
  • [3] Intratympanic gentamicin therapy for control of vertigo in unilateral Meniere's disease: a prospective, double-blind, randomized, placebo-controlled trial
    Postema, Rolf J.
    Kingma, Charlotte M.
    Wit, Hero P.
    Albers, Frans W. J.
    Van Der Laan, Bernard F. A. M.
    ACTA OTO-LARYNGOLOGICA, 2008, 128 (08) : 876 - 880
  • [4] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [5] EFFICACY OF LOW DOSE LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kane, John M.
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S317 - S317
  • [6] Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Meniere's disease: A prospective, double-blind, placebo-controlled, randomized clinical trial
    Stokroos, R
    Kingma, H
    ACTA OTO-LARYNGOLOGICA, 2004, 124 (02) : 172 - 175
  • [7] Efficacy of Intratympanic OTO-104 for the Treatment of Meniere's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies
    Phillips, John
    Mikulec, Anthony A.
    Robinson, James M.
    Skarinsky, David
    Anderson, Jeffery J.
    OTOLOGY & NEUROTOLOGY, 2023, 44 (06) : 584 - 592
  • [8] Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study
    Rask-Andersen, H
    Friberg, U
    Johansson, M
    Stiernschantz, J
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 133 (03) : 441 - 443
  • [9] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [10] DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial - Reply
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Yaffe, K
    NEUROLOGY, 2004, 62 (06) : 1030 - 1030
12345